Moreover, one study reports that NR1H3 and NR1H2 belong to a transcription signature associated with poor CRC clinical outcome independent of lymph node metastasis, distant metastasis, and advanced stage (156). Here, NR1H3 is linked to metastatic malignant neoplasm in the lymph nodes.